Anti-tumour necrosis factor therapy in seronegative spondyloarthritis.
Catherine
Swales
S
Nuffield Orthopoedic Centre NHS Trust, Headington, Oxford.
Bowness
Paul
P
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012217:Rheumatoid Factor / Q000276:immunology*; D025241:Spondylarthritis / Q000188:drug therapy* / Q000276:immunology*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D012217:Rheumatoid Factor